Get the Stockscreener App
0.916
4.69%
-0.0451
After Hours:
.92
0.004
+0.44%
Trxade Health Inc stock is traded at $0.916, with a volume of 310.91K.
It is down -4.69% in the last 24 hours and down -71.10% over the past month.
See More
Previous Close:
$0.9611
Open:
$0.975
24h Volume:
310.91K
Relative Volume:
5.46
Market Cap:
$2.80M
Revenue:
$7.15M
Net Income/Loss:
$4.03M
P/E Ratio:
-0.1696
EPS:
-5.4
Net Cash Flow:
$-11.33M
1W Performance:
-4.64%
1M Performance:
-71.10%
6M Performance:
-87.93%
1Y Performance:
-87.93%
1-Day Range:
$0.915
$1.04
1-Week Range:
$0.8225
$1.05
52-Week Range:
$0.8225
$3.88
Trxade Health Inc Stock (MEDS) Company Profile
Name
Trxade Health Inc
Sector
Industry
Phone
(800) 261 0281
Address
2420 BRUNELLO TRACE, LUTZ, FL
Compare MEDS vs HITI, PETS, SCNX, POM, RDGT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDS
Trxade Health Inc
|
0.916 | 4.44M | 7.15M | 4.03M | -11.33M | -5.40 |
HITI
High Tide Inc
|
2.565 | 215.28M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.81 | 38.15M | 179.02M | -57.29M | -33.01M | -2.7487 |
SCNX
Scienture Holdings Inc
|
0.373 | 19.37M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
0.83 | 7.61M | 0 | 0 | 0 | 0.00 |
RDGT
Ridgetech Inc
|
0.9081 | 2.92M | 111.62M | 762.70K | 16.36M | -85.73 |
Trxade Health Inc Stock (MEDS) Latest News
Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative
Wellgistics Health Inc. (MEDS) Live Share Price, Invest From India - INDmoney
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. - Stock Titan
SCNXScienture Holdings Inc Stock Price and Quote - Finviz
Trxade Health announces name change to Scienture Holdings - Intellectia AI
MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI
MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
MEDS News & Events - Intellectia AI
Wellgistics Health Taps Former Optum, Evernorth Executives in Major Leadership Overhaul for Digital Transformation - Stock Titan
SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC - ACCESS Newswire
TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC. - ACCESS Newswire
Datameds AI (MEDS) Stock Price, News & Analysis - Stock Titan
Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model - ACCESS Newswire
Oragenics Appoints Janet Huffman As Interim CEO - citybiz
Urgent Company Parent Co. Sued By Eat Well Investment Group - Nosh.com
Group Alleges $10M 'Sham' In Fla. Plant-Based Co. Stock Deal - Law360
UK Compounding Pharmacies Market Size & Outlook, 2023-2030 - Grand View Research
TRxADE HEALTH (NASDAQ: MEDS)Share Price - intelligentinvestor.com.au
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
MEDS Price History for Trxade Health Stock - Barchart.com
Trxade Health (MEDS) Q2 2024 Research Summary - AlphaStreet
TRxADE HEALTH, INC 10-Q Report - TradingView
About Us - FinancialContent
Dykema Guides TRxADE in Another Acquisition - Dykema
Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet
TRxADE HEALTH (MEDS) Stock News & Updates - Stock Titan
TRxADE HEALTH, INC. Releases Q1 2024 10-Q Report Highlighting Strategic Shifts and Financial Performance - TradingView
Trxade Group Confronts Compliance Issues and Board Changes - TipRanks
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
TRxADE HEALTH, INC. Releases 10-K Report Highlighting Financial and Strategic Developments - TradingView
TRxADE Health, Inc. Announces Special Cash Dividend - Stock Titan
Trxade Health Surges 40% On Special Dividend - RTTNews
Why Is Trxade Health (MEDS) Stock Up 230% Today? - InvestorPlace
Dykema Completes Sale of Assets for TRxADE Health, Inc. - Dykema
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet
TRxADE HEALTH, INC. Releases Q3 10-Q Report Highlighting Strategic Shifts and Financial Performance - TradingView
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry. - Yahoo Finance
Food technology company prepares to enter plant-based pet nutrition market - Pet Food Processing
The Week in AgriFoodTech: Toyota does indoor farming, Bayer & Pairwise ink deal, cultivated seafood gets big in Japan - AgFunderNews
Superlatus into snacks with protein twists - Food Business News
Perfect Day Agrees To Sell D2C Arm The Urgent Company for $1.25M - Green Queen Media
Trxade Health (MEDS) Stock Is Moving Higher: What's Going On? - Benzinga
Twilio (TWLO) Earnings: 2Q23 Key Numbers - AlphaStreet
Artemis Strategic (ARTE) to Combine with Danam Health in $200M Deal - SPACInsider
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc. - GlobeNewswire
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution - Yahoo Finance
Trxade Health up 68%this time it’s a real price movement on a reverse takeover - Dhaka Tribune
Trxade Health Inc Stock (MEDS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
4.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):